Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Health Discovery Corporation Launches Android Version of Popular MelApp, Melanoma Risk Analysis Mobile Phone App

February 2, 2012 By AxoGen, Inc.

SAVANNAH,
Ga.–(BUSINESS WIRE)–Health Discovery
Corporation, the molecular diagnostics company that launched
MelApp, the first SVM-based image analysis iPhone app for melanoma risk
assessment, today debuts its popular MelApp mobile app for Android™ devices.
Now, health-conscious consumers can easily learn about melanoma and identify
areas on their skin which may need attention from a specialist, anytime,
anywhere with their iPhone, iPod Touch and iPad, as well as Android smartphone.

First launched this summer for iPhone, MelApp uses highly
sophisticated patent protected mathematical algorithms and image based pattern
recognition technology to analyze an uploaded image. The app was validated
using an image database licensed from Johns Hopkins
University Medical
Center and uses a
devices camera feature to deliver a risk analysis of users photographed skin
lesions within seconds. In addition, MelApp can use the smartphones GPS to
refer users to physicians specializing in the diagnosis and treatment of
melanoma for proper medical diagnosis and treatment.

“Being currently used in nearly 50 countries, and having
been named one of the ‘Top 10 Apps That Could Save Your Life in a recent issue
of Parade Magazine, MelApp has become a worldwide success,” stated Stephen D.
Barnhill, M.D. Chairman and CEO of Health Discovery Corporation. “With the launch
of MelApp for Android our goal was to extend the availability of this easy to
use, inexpensive and potentially life-saving app to the more than 46 percent of
the smart phone market that use Android devices, according to Nielsen.”

Now available for iPhone, iPod touch, and iPad, as well as
for Android, MelApp is available for download at a special limited time price
of $1.99 at the following app marketplaces:

  • iTunes App Store – http://itunes.apple.com/us/app/melapp/id446669257?mt=8&ls=1
  • Android Marketplace – https://market.android.com/search?q=MelApp&c=apps

This version of MelApp for Android has been optimized for
the Droid X. For support and technical inquiries, contact support@healthdiscoverylabs.com.

Physicians who diagnose and treat melanoma can become a
subscribing member of HDCs physician referral network by contacting melappreferral@healthdiscoverycorp.com.

About MelApp & Health Discovery Corporation

MelApp uses highly sophisticated patent protected mathematical algorithms and
image based pattern recognition technology to analyze the uploaded image.
MelApp was validated using an image database licensed from Johns Hopkins
University Medical
Center and uses a
devices camera feature to deliver a risk analysis of users photographed skin
lesions within seconds. The app can use the iPhone GPS to refer users to
physicians specializing in the diagnosis and treatment of melanoma for proper
medical follow-up. MelApp by Health Discovery Corporation is available at a
special limited time introductory price of $1.99. For more complete details,
visit http://www.melapp.net, http://www.facebook.com/MelApp or http://twitter.com/#!/SafeHealthApps.

Health Discovery Corporation is a molecular diagnostics
company that uses advanced mathematical techniques to analyze large amounts of
data to uncover patterns that might otherwise be undetectable. It operates
primarily in the emerging field of personalized medicine where such tools are
critical to scientific discovery. Its primary business consists of licensing
its intellectual property and developing its own product line of
biomarker-based diagnostic tests that include human genes and genetic
variations, as well as gene, protein, and metabolic expression differences and
image analysis in digital pathology and radiology. For more information, see www.healthdiscoverycorp.com.

Posted by Sean Fenske, Editor-in-Chief, MDT

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech